ArticleSisli Etfal Hastanesi tip bulteni2025
Cervical lymphadenopathies: A Retrospective Single-Center Analysis of Patients Undergoing Excisional Biopsy.
Article in Sisli Etfal Hastanesi tip bulteni, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Diagnostic Accuracy of Multiparametric Ultrasound Versus Cross-Sectional Imaging for Differentiating Benign and Malignant Cervical Lymph Nodes: A Histopathology-Referenced Retrospective Study.Diagnostics (Basel, Switzerland) · 2026Article
- Comment on "Cervical Lymphadenopathies: A Retrospective Single-Center Analysis of Patients Undergoing Excisional Biopsy".Sisli Etfal Hastanesi tip bulteni · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: The aim of this retrospective study was to evaluate and compare cervical ultrasound findings, fine needle aspiration biopsy (FNAB) results and excisional biopsy results in the diagnosis of patients presenting with cervical lymphadenopathy and to reveal the most common causes. Methods: A total of 137 patients who underwent cervical ultrasonography and FNAB before excision were included in the study. Demographic data, cervical ultrasonographic findings, FNAB pathology results and final pathology results after excisional biopsy were analysed. Results: The pathological results indicated that reactive follicular hyperplasia was diagnosed in 33.6% (n=46) of the patients. A diagnosis of non-Hodgkin lymphoma (NHL) was made in 27.7% (n=38) of cases, while 13.1% (n=18) were diagnosed with Hodgkin lymphoma. Malignant pathology was diagnosed in 66 patients. In the FNAB results of patients diagnosed as malignant, 57 were interpreted as non-diagnostic and suspicious, while 9 were interpreted as benign. Of these, 8 had a pathological examination of lymph node excision that revealed non-Hodgkin lymphoma (NHL), and in one patient with a benign FNAB result, the result of lymph node excision was reported as malignant. Conclusion: Especially in cervical lymphadenopathies in patients over 40 years of age, the possibility of malignancy increases significantly. In lymphoproliferative diseases and in cases accompanied by clinical suspicion, it would be rational to use the direct excisional biopsy option. Although prior fine needle aspiration biopsy may provide significant guidance in metastatic diseases, it should be kept in mind that false negative rates may increase in the diagnosis and staging of lymphoma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.